跳至主要内容
临床试验/NCT01780532
NCT01780532撤回不适用

Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study

Stanford University0 个研究点开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
The lesion visibility on PAI, described using a five-level scale: 1. Not visible 2. Barely visible 3. Fair (or moderately visible) 4. Visible 5. Clearly visible.

研究概览

简要总结

After locating the suspicious lesion/mass with standard of care mammography and/or ultrasound, a photoacoustic scan will be performed in the breast where the lesion is located. After the PA scan a biopsy will be performed, if clinically indicated (based on the mammogram and ultrasound only).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients must have a breast lesion/mass found at physical examination, mammography or ultrasound (US), that has not been surgically resected
  • Patients may have any of the following characteristics:
  • Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer Tamoxifen)
  • Breast implants
  • Previous breast biopsy
  • Previous breast surgery
  • Previous breast cancer
  • High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA) mutations, other gynecologic cancer)
  • Ability to understand and the willingness to sign a written informed consent document

排除标准

  • Patients who have had primary surgical excision of the suspicious finding
  • Pregnant or lactating women

结局指标

主要结局

The lesion visibility on PAI, described using a five-level scale: 1. Not visible 2. Barely visible 3. Fair (or moderately visible) 4. Visible 5. Clearly visible.

时间窗: 6 months

次要结局

  • Measures of hypoxia in the lesion(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanjiv Sam Gambhir

Chair, Dept. of Radiology

Stanford University

相似试验

Photoacoustic Imaging (PAI) of Suspicious Breast... | 临床试验